tekturna dose
- Product Details
- Company Profile
1. The description of tekturna
Tekturna (CAS NO.173334-58-2 ), with its Molecular formula C30H53N3O6·0.5 C4H4O4, contains aliskiren hemifumarate, a renin inhibitor, that is provided as tablets for oral administration. It is a white to slightly yellowish crystalline powder with a molecular weight of 609.8 (free base-551.8). It is soluble in n-octanol, phosphate buffer, and highly soluble in water.
2. Tekturna dosage
Aliskiren (Tekturna) may be used alone or in combination with other antihypertensive agents. The dose of Tekturna that your healthcare provider recommends will vary. There are many factors that can affect your tekturna dosage. For example:
1) whether you are taking other medications.
2) How well you respond to tekturna.
Usually, in the condition of tekturna dosage for High Blood Pressure, the recommended starting dose for treating high blood pressure is 150 mg once daily. Your healthcare provider may increase your Tekturna dosage to 300 mg once daily if necessary.
Hangzhou Holypharm biotech Co.,Ltd., a professional supplier of active pharmaceutical ingredients and intermediates, gave the general tekturna dosage forms:
1) 150 mg light pink biconvex round tablet, imprinted NVR/IL.
2) 300 mg light red biconvex ovaloid round tablet, imprinted NVR/IU.
Tekturna is supplied as a light-pink, biconvex round tablet containing 150 mg of aliskiren, and as a light-red biconvex ovaloid tablet containing 300 mg of aliskiren.
Verified Supplier
HANGZHOU HOLYPHARM BIOTECH CO.,LTD
- Country: China (Mainland)
- Year Established: 2009
- Business License:
- Business type: Other
- Integral:
Contact Details|Similar Products
Escrow ServiceMore
Secure Your Orders With escrow More Transparency,Less Uncertainty